Company Filing History:
Years Active: 2007-2014
Title: Celebrating the Innovations of John Ballantyne in RNA Profiling
Introduction
John Ballantyne, a prolific inventor and researcher based in Orlando, FL, has made significant strides in the field of biotechnology with a focus on messenger RNA (mRNA) technologies. With four patents to his name, his contributions are paving the way for advancements in biological identification and age determination methodologies.
Latest Patents
Among his most notable inventions, Ballantyne's recent patents showcase his innovative approaches to biological analysis. The first is a groundbreaking system for body fluid identification utilizing multiplex real-time polymerase chain reaction (q-PCR). This invention centers around a ribonucleic acid (RNA) based assay system that identifies various body fluids by analyzing messenger RNA expressed in human tissue.
The second notable patent concerns age determination from biological stains through messenger RNA profiling analysis. This patent involves reverse transcription-quantitative polymerase chain reaction (RT-qPCR) assays, systems, methods, and kits that establish the age of an individual from bloodstains or samples of unknown origin. This methodology stands out by identifying novel human newborn fetal-specific genes detected via messenger RNA, offering advancements in forensic science.
Career Highlights
John Ballantyne's innovative work is rooted in his role at the University of Central Florida Research Foundation, Inc. His dedication to advancing scientific understanding and technology has made a significant impact in the fields of biology and forensic analysis.
Collaborations
Throughout his career, Ballantyne has collaborated with notable colleagues, including Michelle Alvarez and Jane Juusola. These partnerships exemplify the collaborative spirit within research institutions and the importance of teamwork in driving scientific progress.
Conclusion
John Ballantyne's contributions to the field of biotechnology demonstrate the vital role of innovation in addressing complex biological questions. His recent patents exemplify the intersection of technology and research, providing tools that enhance our understanding of biological materials and their applications. As he continues his work at the University of Central Florida Research Foundation, Inc., the scientific community eagerly anticipates further advancements from this inventive mind.